For many years, we have been limited in the solutions we could offer our patients suffering from Age-Related Macular Degeneration (AMD). Either we suggested over-the-counter supplements or asked them to endure eye injections. But thankfully, we now have a new, non-invasive, highly effective treatment for our macular degeneration patients.
In this episode, Justin Sather (CEO), Ravi Tanna (VP of Sales), and Dr. Trevor Miranda share how MacuMira works and how it will revolutionize macular degeneration care.
Learn more at MacuMira.com.